AdaptHealth Corp. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AdaptHealth Corp. stock issued during period, value, stock options exercised for the quarter ending 2024-12-31 was $42.00K, a 51.72% decline year-over-year.
- AdaptHealth Corp. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $198.00K, a 63.20% decline year-over-year.
- AdaptHealth Corp. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was -$45.00K.
- AdaptHealth Corp. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $545.00K.
- AdaptHealth Corp. stock issued during period, value, stock options exercised for fiscal 2024 was $742.00K, a 26.41% increase from fiscal 2023.
- AdaptHealth Corp. stock issued during period, value, stock options exercised for fiscal 2023 was $587.00K, a 76.61% decline from fiscal 2022.
- AdaptHealth Corp. stock issued during period, value, stock options exercised for fiscal 2022 was $2.51M, a 79.63% decline from fiscal 2021.
- AdaptHealth Corp. stock issued during period, value, stock options exercised for fiscal 2021 was $12.32M.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2024-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $742.00K 10-K · filed 2026-02-24 |
| 2024-09-30 | $198.00K 10-Q · filed 2025-11-04 | $785.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | -$45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.13M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $545.00K 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $587.00K 10-K · filed 2026-02-24 |
| 2023-09-30 | $538.00K 10-Q · filed 2024-11-05 | |
| 2022-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $2.51M 10-K · filed 2025-02-25 |
| 2022-09-30 | $665.00K 10-Q · filed 2023-11-07 | $1.58M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $10.76M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $723.00K 10-Q · filed 2023-11-07 | $13.08M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $220.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $12.32M 10-K · filed 2024-02-27 |
| 2021-09-30 | $9.84M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $2.30M 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Addus HomeCare Corp (ADUS) | United States | $2.129B | 17.80 |
| Aveanna Healthcare Holdings, Inc. (AVAH) | United States | $2.703B | 7.22 |
| Option Care Health, Inc. (OPCH) | United States | $3.602B | 20.52 |
| CHEMED CORP (CHE) | United States | $6.474B | 22.14 |
| BrightSpring Health Services, Inc. (BTSG) | United States | $11.078B | 37.65 |